0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurodevelopmental"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
EUR$186USDGBP
EUR$266USDGBP
EUR$635USDGBP
EUR$169USDGBP
EUR$160USDGBP
EUR$308USDGBP
EUR$160USDGBP
EUR$212USDGBP
Loading Indicator

The Neurodevelopmental market is a subset of Neurology that focuses on the development of the nervous system. It encompasses the diagnosis, treatment, and management of conditions that affect the development of the brain, spinal cord, and peripheral nervous system. This includes conditions such as autism, cerebral palsy, Down syndrome, and intellectual disabilities. Neurodevelopmental disorders can be caused by genetic, environmental, or other factors. Treatment options may include medications, physical therapy, occupational therapy, and speech therapy. Some companies in the Neurodevelopmental market include AbbVie, Biogen, Novartis, Pfizer, and Shire. These companies develop and market treatments for neurodevelopmental disorders, as well as provide support services for patients and families. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more